EGFR and cancer: The anticancer activity of recently synthesized thiadiazole derivatives was attributed to the inhibition of the human epidermal growth factor receptors (HERs), which are receptor protein tyrosine kinases (PRTKs), that, affecting the secretion of pro-angiogenesis factors, cause an acceleration of cancer development [16].